Complex Generics: US FDA, Sponsors View Roadblocks Very Differently

 
• By Derrick Gingery
FDA building
The US FDA approval process for complex generic drugs continues to vex sponsors, who want a more predictable timeline • Source: Shutterstock

More from Generics

More from Products